207405-62-7

Basic information

• Product Name: 5-Amino-2-aza-bicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester
• Synonyms: 5-Amino-2-aza-bicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester;2-azabicyclo[2.2.1]heptane-2-carboxylic acid, 5-amino-, 1,1-dimethylethyl ester
• CAS NO: 207405-62-7
• Molecular Formula: C11H20N2O2
• Molecular Weight: 212.2887
• Mol File: 207405-62-7.mol

Chemical Properties

• Boiling Point: 294.8±33.0 °C(Predicted)
• Appearance: /
• Density: 1.111±0.06 g/cm3(Predicted)
• PKA: 9.95±0.20(Predicted)
• CAS DataBase Reference: 5-Amino-2-aza-bicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Amino-2-aza-bicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester(207405-62-7)
• EPA Substance Registry System: 5-Amino-2-aza-bicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester(207405-62-7)

Safety Data

• Hazardous Substances Data: 207405-62-7(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
5-Amino-2-aza-bicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester is used as a building block for the production of complex organic molecules. Its protected carboxylic acid group allows for selective reactions and subsequent deprotection, facilitating the synthesis of a wide range of compounds.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 5-Amino-2-aza-bicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester is used as a precursor in the development of drugs and other bioactive compounds. Its unique structure and reactivity make it a promising candidate for the creation of novel therapeutic agents.
Used as a Chiral Ligand in Asymmetric Catalysis:
5-Amino-2-aza-bicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester is employed as a chiral ligand in asymmetric catalysis. Its specific stereochemistry enables the selective formation of enantiomerically pure products, which is crucial for the synthesis of biologically active compounds.
Used as a Precursor in the Production of Fine Chemicals:
In the fine chemicals industry, 5-Amino-2-aza-bicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester serves as a precursor for the synthesis of high-value specialty chemicals. Its versatility and reactivity contribute to the production of a variety of high-quality compounds for various applications.

Upstream product

• 1400808-00-5 5-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester 
• 207405-64-9 tert-butyl (1R,4R)-5-(benzylamino)-2-azabicyclo[2.2.1]heptane-2-carboxylate 
• 542-92-7 cyclopenta-1,3-diene 
• 24424-99-5 di-tert-butyl dicarbonate 
• 198835-06-2 5-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester 
• 207405-61-6 5-oximino-2-azabicyclo[2.2.1]heptane-2-carboxylic acid tert-butyl ester 
• 207405-64-9 C₁₈H₂₆N₂O₂ 
• 207405-64-9 (1R,4R,5R)-tert-butyl 5-(benzylamino)-2-azabicyclo[2.2.1]heptanes-2-carboxylate 
• 702666-73-7 tert-butyl (1R,4S)-(+)-2-azabicyclo[2.2.1]hept-5-ene-2-carboxylate 
• 207405-69-4 (1R,4R,5S)-tert-butyl 5-hydroxy-2-azabicyclo[2.2.1]heptanes-2-carboxylate 
• 79200-56-9 (-)-2-azabicyclo[2.2.1]hept-5-en-3-one 
• 207405-64-9 tert-butyl 5-(benzylamino)-2-azabicyclo[2.2.1]heptane-2-carboxylate 
• 198835-06-2 tert-butyl 5-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate 
• 49805-30-3 2-azabicyclo[2.2.1.]hept-5-en-3-one 

Relevant articles and documents

NOVEL QUINOLINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE

The present invention relates to compounds of formula (I), (I), wherein R1, R2 and R3 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.

Nitrogen-containing heterocyclic derivative and preparation thereof

The invention discloses a nitrogen-containing heterocyclic compound as shown in a formula (I), a stereoisomer, a solvate, a metabolite, a pharmaceutically acceptable salt, a co-crystal or a prodrug of the nitrogen-containing heterocyclic compound, a pharmaceutical composition of the nitrogen-containing heterocyclic compound, a preparation method of the nitrogen-containing heterocyclic compound, and an application of the nitrogen-containing heterocyclic compound in prevention and treatment of autotaxin mediated diseases.

NITROGEN HETEROCYCLIC COMPOUNDS AND METHODS OF USE

The present disclosure relates to compounds of formula (I): and pharmaceutically acceptable salts and stereoisomers thereof. The present disclosure also relates to methods of preparing the compounds, compositions comprising the compounds, and methods of using the compounds as inhibitors of receptor tyrosine kinases, in particular oncogenic mutants of ErbB-receptors e.g. in the treatment of cancer.

Synthesis and biological evaluation of pyrimidine derivatives with diverse azabicyclic ether/amine as novel GPR119 agonist

A class of novel pyrimidine derivatives bearing diverse conformationally restricted azabicyclic ether/amine were designed, synthesized and evaluated for their GPR119 agonist activities against type 2 diabetes. Most compounds exhibited superior hEC50

TRICYCLIC GYRASE INHIBITORS FOR USE AS ANTIBACTERIAL AGENTS

Disclosed herein are compounds having the structure of Formula I and pharmaceutically suitable salts, esters, and prodrugs thereof that are useful as antibacterially effective tricyclic gyrase inhibitors. In addition, species of tricyclic gyrase inhibitors compounds are also disclosed herein. Related pharmaceutical compositions, uses and methods of making the compounds are also contemplated.

TRICYCLIC GYRASE INHIBITORS

Disclosed herein are compounds having the structure of Formula I and pharmaceutically suitable salts, esters, and prodrugs thereof that are useful as antibacterially effective tricyclic gyrase inhibitors. Related pharmaceutical compositions, uses and methods of making the compounds are also contemplated.

BRIDGED BICYCLIC RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE

The present invention is directed to synthetic bridged bicyclic compounds that are inhibitors of rho-associated protein kinase. The present invention is also directed to pharmaceutical compositions comprising such compounds and a pharmaceutically acceptab

Improved synthesis of monoprotected 5- and 6-amino-2-azanorbornanes

(Chemical Equation Presented) An improved synthesis of Boc-monoprotected 5- and 6-amino-2-azanorbornanes is reported. The synthetic scheme consists of five steps and allows multigram quantities of the title compounds to be obtained. The regio- and stereochemistries of the products are established by two-dimensional NMR experiments. Copyright Taylor & Francis Group, LLC.

PIPERAZINO DERIVATIVES AS NEUROKININ ANTAGONISTS

The invention relates to compounds of formula (I) wherein Z, Rc, y, m, u, Ar2, n, X, Rc', l and Ar2 are as described herein. These compounds are neurokinin antagonists. These compounds are useful in the treatment of chronic airway diseases such as asthma.